Lexaria Bioscience Corp. (NASDAQ: LEXX) – A Zacks Update
Lexaria just released its mid-year update, highlighting its key milestones so far and its objectives going forward, summarized in a…
Blog
QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Translating ESG-Linked Ambitions into Practice
Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and…
QualityStocksNewsBreaks – GeoSolar Technologies Inc. Taking Part in Shift Toward a Greener Future
GeoSolar Technologies (“GST”), a Colorado-based climate technology company, seeks to power a home that is more environmentally friendly, healthier and…
QualityStocksNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Moves to Acquire ‘Safety Shot’ – the World’s First Rapid Blood Alcohol Detox Drink
Jupiter Wellness (NASDAQ: JUPW), a diversified company that supports health and wellness, today announced it has executed an asset purchase…
First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) Is ‘One to Watch’
First Tellurium in June 2023 successfully uplisted from the OTC Pink Market to the OTCQB Venture Market First Tellurium has…
QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) to Commence 2023 ‘Strikingly Different’ EV Tour
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that the Mullen FIVE EV Crossover will be…
D-Wave Quantum Inc. (NYSE: QBTS) Technology Ready to Answer Call of Proposed Legislation for Near-Term Quantum Applications to Solve Optimization Problems
Legislation presented to Congress calls for the United States government to develop and adopt near-term quantum computing – some within…
Data443 Risk Mitigation Inc. (ATDS) Upgrades Product Offering; Committed to Enabling Businesses to Manage Data Privacy in Cloud, Hybrid Environments
Data is one of the most valuable and critical assets for today's businesses, but with cyber-attacks on the rise it…
Genprex Inc. (NASDAQ: GNPX) Reports Positive Results from its Phase 1 Acclaim-1 Clinical Trial; Releases Patient Video Describing Positive Experience
Genprex recently announced that its lead drug candidate, REQORSA(R), was well tolerated with no dose-limiting toxicities in the Phase 1…
QualityStocksNewsBreaks – Data443 Risk Mitigation Inc. (ATDS) Moving to Expand into Larger Enterprise Market
Data443 Risk Mitigation (OTC: ATDS), a data security and privacy software company, recently announced next steps to acquire select assets…